"The Institute gave us an opportunity to test our methods to see if they could work in practice instead of theory."

– Christopher Zarins, MD, Co-founder of HeartFlow

Portfolio

Since beginning operations in late 2007, The Fogarty Institute for Innovation has provided support to eight innovative entrepreneurs in our “Innovation: Cultivation” program. HeartFlow has moved on to establish independent offices in Redwood City, CA. Our other innovators in residence are in various stages of development, but all are moving toward independence with astounding speed and efficiency.

Below is a summary of where each of our innovators stand to date in the development process.

Graduated
Company	Technology	Patient Benefit
	Patient-specific, non- invasive stenosis detection.	Eliminates ~1M invasive diagnostic procedures, reduces patient risk, and saves $13B/yr in healthcare costs.
In Residence
Company	Technology	Patient Benefit
	Percutaneous approach to restoring valve competency in the deep leg veins.	Cure for ulcers and other painful, debilitating complications in the legs due to poor vein function.
	Miniaturized sewing machine for use in laparoscopic surgery.	Allows surgeons the ability to place a continuous chain of stitches with a simple system.
	Electrical muscle stimulation for critical care patients.	Prevents muscle deterioration in extended-duration critical care patients.
	Percutaneous treatment of peripheral vascular disease.	Eliminates 200K highly invasive vascular bypass surgeries per year.
	Web-based, high- resolution, interactive, anatomical visualization for surgical training.	Broader patient access and better outcomes for new surgical procedures.